76 related articles for article (PubMed ID: 34840207)
21. Efficacy of MEK inhibition in patients with histiocytic neoplasms.
Diamond EL; Durham BH; Ulaner GA; Drill E; Buthorn J; Ki M; Bitner L; Cho H; Young RJ; Francis JH; Rampal R; Lacouture M; Brody LA; Ozkaya N; Dogan A; Rosen N; Iasonos A; Abdel-Wahab O; Hyman DM
Nature; 2019 Mar; 567(7749):521-524. PubMed ID: 30867592
[TBL] [Abstract][Full Text] [Related]
22. Activating MAPK1 (ERK2) mutation in an aggressive case of disseminated juvenile xanthogranuloma.
Chakraborty R; Hampton OA; Abhyankar H; Zinn DJ; Grimes A; Skull B; Eckstein O; Mahmood N; Wheeler DA; Lopez-Terrada D; Peters TL; Hicks JM; Elghetany T; Krance R; Poulikakos PI; Merad M; McClain KL; Allen CE; Parsons DW
Oncotarget; 2017 Jul; 8(28):46065-46070. PubMed ID: 28512266
[TBL] [Abstract][Full Text] [Related]
23. BRAF V600E mutation in pediatric intracranial and cranial juvenile xanthogranuloma.
Techavichit P; Sosothikul D; Chaichana T; Teerapakpinyo C; Thorner PS; Shuangshoti S
Hum Pathol; 2017 Nov; 69():118-122. PubMed ID: 28504206
[TBL] [Abstract][Full Text] [Related]
24. Liver macrophages in tissue homeostasis and disease.
Krenkel O; Tacke F
Nat Rev Immunol; 2017 May; 17(5):306-321. PubMed ID: 28317925
[TBL] [Abstract][Full Text] [Related]
25. Successful treatment of systemic juvenile xanthogranulomatosis with cytarabine and 2-chlorodeoxyadenosine: case report and review of the literature.
Maintz L; Wenzel J; Irnich M; Reinhard H; Bieber T
Br J Dermatol; 2017 Feb; 176(2):481-487. PubMed ID: 27312940
[TBL] [Abstract][Full Text] [Related]
26. BRAF V600 mutations in Langerhans cell histiocytosis with a simple and unique assay.
Tatsuno M; Shioda Y; Iwafuchi H; Yamazaki S; Iijima K; Takahashi C; Ono H; Uchida K; Okamura O; Matubayashi M; Okuyama T; Matsumoto K; Yoshioka T; Nakazawa A
Diagn Pathol; 2016 Apr; 11():39. PubMed ID: 27094161
[TBL] [Abstract][Full Text] [Related]
27. Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages.
Emile JF; Abla O; Fraitag S; Horne A; Haroche J; Donadieu J; Requena-Caballero L; Jordan MB; Abdel-Wahab O; Allen CE; Charlotte F; Diamond EL; Egeler RM; Fischer A; Herrera JG; Henter JI; Janku F; Merad M; Picarsic J; Rodriguez-Galindo C; Rollins BJ; Tazi A; Vassallo R; Weiss LM;
Blood; 2016 Jun; 127(22):2672-81. PubMed ID: 26966089
[TBL] [Abstract][Full Text] [Related]
28. Recent advancement of molecular mechanisms of liver fibrosis.
Seki E; Brenner DA
J Hepatobiliary Pancreat Sci; 2015 Jul; 22(7):512-8. PubMed ID: 25869468
[TBL] [Abstract][Full Text] [Related]
29. Mutually exclusive recurrent somatic mutations in MAP2K1 and BRAF support a central role for ERK activation in LCH pathogenesis.
Chakraborty R; Hampton OA; Shen X; Simko SJ; Shih A; Abhyankar H; Lim KP; Covington KR; Trevino L; Dewal N; Muzny DM; Doddapaneni H; Hu J; Wang L; Lupo PJ; Hicks MJ; Bonilla DL; Dwyer KC; Berres ML; Poulikakos PI; Merad M; McClain KL; Wheeler DA; Allen CE; Parsons DW
Blood; 2014 Nov; 124(19):3007-15. PubMed ID: 25202140
[TBL] [Abstract][Full Text] [Related]
30. Association of both Langerhans cell histiocytosis and Erdheim-Chester disease linked to the BRAFV600E mutation.
Hervier B; Haroche J; Arnaud L; Charlotte F; Donadieu J; Néel A; Lifermann F; Villabona C; Graffin B; Hermine O; Rigolet A; Roubille C; Hachulla E; Carmoi T; Bézier M; Meignin V; Conrad M; Marie L; Kostrzewa E; Michot JM; Barete S; Taly V; Cury K; Emile JF; Amoura Z;
Blood; 2014 Aug; 124(7):1119-26. PubMed ID: 24894769
[TBL] [Abstract][Full Text] [Related]
31. Juvenile xanthogranuloma: diverse presentations of noncutaneous disease.
Murphy JT; Soeken T; Megison S; Perez E
J Pediatr Hematol Oncol; 2014 Nov; 36(8):641-5. PubMed ID: 24065046
[TBL] [Abstract][Full Text] [Related]
32. Disseminated intracranial juvenile xanthogranulomatosis in a neonate without cutaneous lesions.
Gressot LV; Patel AJ; Bollo RJ; Mohila CA; Jea A
J Neurosurg Pediatr; 2013 Aug; 12(2):187-91. PubMed ID: 23790105
[TBL] [Abstract][Full Text] [Related]
33. High prevalence of BRAF V600E mutations in Erdheim-Chester disease but not in other non-Langerhans cell histiocytoses.
Haroche J; Charlotte F; Arnaud L; von Deimling A; Hélias-Rodzewicz Z; Hervier B; Cohen-Aubart F; Launay D; Lesot A; Mokhtari K; Canioni D; Galmiche L; Rose C; Schmalzing M; Croockewit S; Kambouchner M; Copin MC; Fraitag S; Sahm F; Brousse N; Amoura Z; Donadieu J; Emile JF
Blood; 2012 Sep; 120(13):2700-3. PubMed ID: 22879539
[TBL] [Abstract][Full Text] [Related]
34. BRAFV600E mutant protein is expressed in cells of variable maturation in Langerhans cell histiocytosis.
Sahm F; Capper D; Preusser M; Meyer J; Stenzinger A; Lasitschka F; Berghoff AS; Habel A; Schneider M; Kulozik A; Anagnostopoulos I; Müllauer L; Mechtersheimer G; von Deimling A
Blood; 2012 Sep; 120(12):e28-34. PubMed ID: 22859608
[TBL] [Abstract][Full Text] [Related]
35. A rare case of neonatal systemic xanthogranulomatosis with severe hepatic disease and metachronous skin involvement.
Papadakis V; Volonaki E; Katsibardi K; Stefanaki K; Valari M; Anagnostakou M; Polychronopoulou S
J Pediatr Hematol Oncol; 2012 Apr; 34(3):226-8. PubMed ID: 22031119
[TBL] [Abstract][Full Text] [Related]
36. Solitary juvenile xanthogranuloma in the lung of a young adult.
Lin L; Salisbury EL; Gardiner I; Varikatt W
Pathology; 2011 Aug; 43(5):503-7. PubMed ID: 21753717
[No Abstract] [Full Text] [Related]
37. Heterozygous germline mutations in the CBL tumor-suppressor gene cause a Noonan syndrome-like phenotype.
Martinelli S; De Luca A; Stellacci E; Rossi C; Checquolo S; Lepri F; Caputo V; Silvano M; Buscherini F; Consoli F; Ferrara G; Digilio MC; Cavaliere ML; van Hagen JM; Zampino G; van der Burgt I; Ferrero GB; Mazzanti L; Screpanti I; Yntema HG; Nillesen WM; Savarirayan R; Zenker M; Dallapiccola B; Gelb BD; Tartaglia M
Am J Hum Genet; 2010 Aug; 87(2):250-7. PubMed ID: 20619386
[TBL] [Abstract][Full Text] [Related]
38. Recurrent BRAF mutations in Langerhans cell histiocytosis.
Badalian-Very G; Vergilio JA; Degar BA; MacConaill LE; Brandner B; Calicchio ML; Kuo FC; Ligon AH; Stevenson KE; Kehoe SM; Garraway LA; Hahn WC; Meyerson M; Fleming MD; Rollins BJ
Blood; 2010 Sep; 116(11):1919-23. PubMed ID: 20519626
[TBL] [Abstract][Full Text] [Related]
39. Treatment of juvenile xanthogranuloma.
Stover DG; Alapati S; Regueira O; Turner C; Whitlock JA
Pediatr Blood Cancer; 2008 Jul; 51(1):130-3. PubMed ID: 18338395
[TBL] [Abstract][Full Text] [Related]
40. Disseminated juvenile xanthogranulomatosis in a newborn resulting in liver transplantation.
Haughton AM; Horii KA; Shao L; Daniel J; Nopper AJ
J Am Acad Dermatol; 2008 Feb; 58(2 Suppl):S12-5. PubMed ID: 18191690
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
